SB 405 amends Michigan's "Administration of Opioid Antagonists Act" by revising the definition of "governmental agency" to explicitly exclude school district boards, public school academies, and licensed healthcare providers (under Public Health Code Part 209). This change means these entities will no longer be subject to the act's requirements regarding opioid antagonist access and training. The bill directly affects school districts, public school academies, and licensed healthcare facilities by removing them from the scope of the law. The amendment clarifies which organizations must comply with the act's provisions, focusing on state and local government entities rather than schools or healthcare providers. This is a technical definitional update with no new requirements or funding changes.
SB 154 makes it a crime to obstruct access to healthcare facilities, such as clinics or hospitals. It directly affects individuals who block entrances, interfere with patients or staff, or prevent access to medical services. The bill creates new criminal penalties for these actions under a newly established legal section. This law applies broadly to all healthcare facilities providing medical services, without specifying particular types of care.
SB 155 amends sentencing guidelines to address crimes specifically targeting access to healthcare facilities, such as blocking entrances or threatening staff. It would establish new sentencing standards for these offenses under Michigan's criminal code (MCL 777.13n). The bill directly affects individuals convicted of obstructing healthcare access, potentially altering their prison terms or penalties. However, the provided context does not detail the exact sentencing changes or specific crime definitions. This summary is based solely on the bill's title and official reference, without additional policy specifics.
SB 180 is a funding bill that allocates $39.29 billion to Michigan's Department of Health and Human Services (DHHS) for the 2025-2026 fiscal year. It provides specific funding for key programs including $276 million for department administration and management, $195 million for child support enforcement operations, and $197 million for community services like homeless programs, diaper assistance, and housing support. The bill directly affects DHHS operations and the state's recipients of these services, such as families using child support enforcement, homeless individuals accessing shelter programs, and low-income households receiving food or housing aid. It establishes the financial framework for these programs but does not change their underlying policies or eligibility rules.
Senate Bill 33 amends Michigan's Estates and Protected Individuals Code concerning patient advocate designations. The bill allows individuals to include specific instructions within their patient advocate designation regarding desired life-sustaining treatment, even if they are pregnant. It removes the existing legal prohibition that prevents patient advocates from making decisions to withhold or withdraw life-sustaining treatment from a pregnant patient if such a decision would result in the patient's death. This change enables a patient advocate to follow a pregnant patient's pre-expressed wishes concerning end-of-life care.
SB 94 prohibits drug manufacturers, wholesalers, and distributors from restricting 340B program pharmacies from accessing or receiving 340B drugs, which are discounted medications for safety-net healthcare providers. It requires 340B entities (like community health centers) to submit annual compliance reports starting in 2026, including program audits and community impact details. Additionally, drug manufacturers must report price increases exceeding 15% for drugs costing over $40 per treatment course, including cost data and patent details. These provisions directly affect pharmaceutical companies, participating pharmacies, and healthcare providers enrolled in the federal 340B drug pricing program.
